Ads by Google
Stomach-reduction surgery is excellent treatment for severe diabetes.
There are three million more diabetics in The United States in the last two years. It's now estimated there are 24 million American diabetics - that's the eight percent of the population. The vast majority of these are Type 2 diabetics.
A new consumer guide for Hispanic adults who have type 2 diabetes and need information to help them compare various oral medications for their illness, has been released by the Agency for Healthcare Research and Quality.
Researchers have discovered that a significant portion of people who have had type 1 diabetes for 50 or more years still have the capacity to produce insulin, a finding that has potential implications for improved treatment for all with the disease.
New research shows that there is a link between diabetes and depression. If you have diabetes you may get depressed, but if you are suffering from depression you may get diabetes.
Some patients with type 2 diabetes can control their disease for years yet avoid insulin injections by using multiple classes of oral diabetic medications.
This study also showed that patients who switched from BYETTA injection after 30 weeks to exenatide once weekly experienced additional improvements in A1C and fasting plasma glucose.
Synvista Therapeutics announced data from three Phase 2 trials of SYI-2074 in Type 2 diabetic patients.
Sanford Health leaders announced the focus of the Sanford Project is curing type 1 diabetes via the body's natural ability to regenerate beta cells. Identified as the attack on one of the greatest health concerns of our time, Sanford Health is dedicating health research resources to cure type 1 diabetes, also known as juvenile diabetes.
New results from the world's largest ever study of diabetes treatments show that intensive blood glucose control using modified release gliclazide and other drugs as required, protects patients against serious complications of the disease.
At the 68th Scientific Sessions of the American Diabetes Association in San Francisco several studies were presented evaluating the impact of blood sugar control to reduce diabetes-related complications in patients.
KineMed and Daiichi Sankyo announced that researchers have discovered a key difference in bile acid metabolism in people with type 2 diabetes which may suggest a newly identified underlying disorder.
Microspheres carrying targeted nucleic acid molecules fabricated in the laboratory have been shown to prevent and even reverse new-onset cases of type 1 diabetes in animal models. The results of these studies were reported by diabetes researchers at the John G. Rangos Sr. Research Center at Children's Hospital of Pittsburgh of UPMC and Baxter Healthcare Corporation.
Clinical study in the search for diabetes treatment shows that liraglutide provides statistically significantly better blood glucose control than exenatide.
Licensed pesticide applicators who used chlorinated pesticides on more than 100 days in their lifetime were at greater risk of diabetes.
Subjects with type 1 or type 2 diabetes who self-monitor their blood glucose levels more frequently and use the results to adjust treatment regimens can achieve improved glucose control.
The risk of developing type 2 diabetes in women is significantly increased as a result of either low cardiorespiratory fitness or higher Body Mass Index (BMI), and a combination of the two increases the risk the most.
Pycnogenol, an antioxidant plant extract from the bark of the French maritime pine tree, reduces blood sugar in type II diabetes patients, allows people to lower their antihypertensive medication and improves cardiovascular disease risk factors.
Researchers who reported earlier this year that an inexpensive, non-steroidal anti-inflammatory drug called salsalate might prevent type 2 diabetes are now reporting that the drug may also be beneficial in the treatment of the disease.